Company news

From our team and our partners.

Company milestones, scientific meetings and work shared with the IVD community.

A new office in Modena

FirsTeckBio moved to Via Emilia Ovest 622 in May 2026. The Modena office is the contact point for our Italian product, regulatory and clinical activities.

MEDICA 2025, Düsseldorf

FirsTeckBio participated in MEDICA 2025 at Hall 3, Booth F88, meeting IVD and medical-device companies to discuss products and European project requirements.

Performance findings at Elas National Congress

The 2025 congress programme included performance posters covering cardiac biomarkers, red blood cell folate and cytokines.

Four performance posters at Euromedlab

At Euromedlab 2025 in Brussels, four performance evaluation posters covered hs-cTnT, hs-cTnI, NT-proBNP and D-Dimer. The findings contribute to discussion of assay performance in laboratory practice.

Cytokine markers and clinical outcomes

A 2025 research publication examined cytokine markers including IL-1β, IL-2R, IL-6, IL-8, IL-10 and TNF-α in relation to clinical outcome prediction.